Correlation between mutations in p53 gene and protein expression in human lymphomas

American Journal of Hematology

Volumn 55, Issue 1, 1997, Pages 1-8

  Martinez Delgado, B ^a,c   Robledo, M ^a   Arranz, E ^a   Infantes, F ^a   Echezarreta, G ^b   Marcos, B ^b   Sanz, C ^b   Rivas, C ^b   Benitez, J ^a  

^a Jimenez Diaz Fundation   (Spain)

^b Jimenez Diaz Foundation   (Spain)

^c Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Lymphomas; Mutations; p53; Protein overexpression

Indexed keywords

PROTEIN P53;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPHOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; CHROMOSOME DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HETEROZYGOTE; HODGKIN DISEASE; HUMANS; LYMPHOMA; LYMPHOMA, B-CELL; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030958459     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199705)55:1<1::AID-AJH1>3.0.CO;2-Y     Document Type: Article

References (39)

1. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A: Wild type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukine-6. Nature 352:345, 1991.
2. Shaw P, Bavey R, Tardy S, Sahli R, Sordat B, Costa J: Induction of apoptosis by wild type p53 in human colon tumors derived cell line. Proc Natl Acad Sci USA 89:4495, 1992.
3. Fritsche M, Haessler C, Brandner G: Production of nuclear accumulation of the tumor suppressor protein p53 by DNA damaging agents. Oncogene 8:307, 1993.
4. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 351:453, 1991.
5. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253:49, 1991.
6. Caron de Formentel C, Soussi T: TP53 tumour suppressor gene: A model for investigating human mutagenesis. Genes Chrom Cancer 4:1, 1992.
7. Gaidano G, Ballerini P, Gong JC, lnghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, Dalla-Favera R: p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 88:5913, 1991.
8. Doglioni C, Pelosio P, Mombello A, Scarpa A, Chilosi M: Immunohistochemical evidence of abnormal expression of the antioncogene encoded p53 phosphoprotein in Hodgkin's disease and CD30+ anaplastic lymphomas. Hematol Pathol 5:67, 1991.
9. Li CC, O'Connell CD, Beckwith M, Longo DL: Detection of p53 mutations in B-cell non-Hodgkin's lymphoma cell lines. Leukemia 9:650, 1995.
10. Soini Y, Paakko P, Alavaikko M, Vahakangas K: p53 expression in lymphatic malignancies. J Clin Pathol 45:1011, 1992.
11. Said JW, Barrera R, Shintaku P, Nakamura H, Koeffler HP: Immunohistochemical analysis of p53 expression in malignant lymphomas. Am J Pathol 141:1343, 1992.
12. Adamson DJA, Thompson WD, Dawson AA, Bennett B, Haites NE: p53 mutations and expression in lymphoma. Br J Cancer 72:150, 1995.
13. Lennert K, Feller AC: "Histopathology of non-Hodgkin's Lymphoma." Berlin: Springer-Verlag, 1992.
14. Trainor KJ, Brisco MJ, Wan JH, Neoh S, Grist S, Morley AA: Gene rearrangement in B and T lymphoproliferative disease detected by polymerase chain reaction. Blood 78:192, 1991.
15. Robledo M, Martinez B, Trujillo MJ, Gonzalez-Ageitos A, Rivas C, Benitez J: Genetic instability on microsatellites in hematological neoplasms. Leukemia 9:960, 1995.
16. Horn GT, Richards B, Klnger KW: Amplification of a highly polymorphic VNTR segment by the polymerase chain reaction. Nucleic Acids Res 17:2140, 1989.
17. Jones MH, Nakamura Y: Detection of loss of heterozigosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chrom Cancer 5:89, 1992.
18. Miwa K, Miyamoto S, Kato H, Imamura T, Nishida M, Yoshikawa Y, Nagata Y, Wake N: The role of p53 inactivation in human cervical cell carcinoma development. Br J Cancer 71:219, 1995.
19. Lehman TA, Bennett WP, Metcalf RA, Welch JA, Ecker J, Modeli RV, Ullrich S, Romano JW, Appella E, Testa JR, Gerwin BI, Harris CC: p53 mutations, ras mutations and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res 51:4090, 1991.
20. Buchman VL, Chuenekov PM, Ninkina NN, Samarina OP, Georgiev GP: A variation in the structure of the protein coding region of the human p53 gene. Gene 70:245, 1988.
21. Kocialkowski S, Pezzella F, Morrison M, Jones S, Laha A, Harris L, Mason DY, Gatter KC: Mutations in the p53 gene are not limited to the classic hot spots and are not predictive of p53 protein expression in high-grade non Hodgkins lymphome. Br J Haematol 89:55, 1995.
22. Shiraishi Y: p53 mutations in fresh lymphocytes, B-cell lymphoblastoid cell lines and their transformed cell lines originating from Bloom syndrome patient. Cancer Genet Cytogenet 68:70, 1993.
23. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-termination inhibitors. Proc Natl Acad Sci USA 74:5463, 1977.
24. Carbone D, Chiba J, Mitsudomi T: Polymorphism at codon 213 within the p53 gene. Oncogene 6:1691, 1991.
25. Buller RE, Skilling JS, Kaliszewski S, Niemann T, Anderson B: Absence of significant germ line p53 mutations in ovarian cancer patients. Gynecol Oncol 58:368, 1995.
26. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B: Mutations in the p53 gene occur in diverse human tumor types. Nature 342:705, 1989.
27. Fenaux P, Jonveaux P, Quiquandon I, Preudhomme C, Lai JL, Vanrumbeke M, Loucheux-Lefebvre MH, Bauters F, Berger R, Kerckaert JP: Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: a report on 60 cases. Leukemia 6:42, 1992.
28. Fenaux P, Preudhomme C, Lai JL, Quiquandon I, Jonveaux P, Vanrumbeke M, Sartiaux C, Morel P, Loucheux LM, Bauters F: Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: A report on 39 cases with cytogenetic analysis. Leukemia 6:246, 1992.
29. Sakashita A, Hattori T, Miller CW, Suzushima H, Asou N, Takatsuki K: Mutations of the p53 gene in adult T-cell leukemia. Blood 79:477, 1992.
30. Ichikawa A, Hotta T, Takagi N, Tsushita K, Kinoshita T, Nagai H, Murakami Y, Hayashi K, Saito H: Mutation of p53 gene and their relation to disease progression in B-cell lymphomas. Blood 79:2701, 1992.
31. Villuendas R, Piris MA, Algara P, Sanchez-Beato M, Sanchez-Verde L, Martinez JC, Orradre JL, García P, Lopez C, Martinez P: The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations. Blood 82:3151, 1993.
32. Xerri L, Bouabdallah R, Carmelo J, Hassoun J: Expression of the p53 gene in Hodgkin's disease: Dissociation between immunohistochemistry and clinicopathological data. Hum Pathol 25:449, 1994.
33. Dix B, Robbins P, Carrello S, Hoose A, lacopetta B. Comparison of p53 gene mutations and protein overexpression in colorectal carcinoma. Br J Cancer 70:585, 1994.
34. Zhang W, Hu G, Deisseroth A: Polymorphism at codon 72 of the p53 gene in human acute myelogenous leukemia. Gene 117:271, 1992.
35. Weston A, Ling-Cawley HM, Caporaso NE, Bowman ED, Hoover RN, Trump BF, Harris CC: Determination of the allelic frequencies of an L-myc and p53 polymorphism in human lung cancer. Carcinogenesis 15:583, 1994.
36. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B: Amplification of a gene encoding a p53 associated protein in human sarcomas. Nature 358:80, 1992.
37. Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES, Raffeld M: p53 mutations are associated with progression in follicular lymphomas. Blood 82:1994, 1993.
38. Lo Coco F, Gaidano G, Loine DC, Offit K, Chaganti RKS, DallaFavera R: p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 82:2289, 1993.
39. Nishimura S, Asou N, Suzushima H, Okubo T, Fujimoto T, Osato M, Yamasaki H, Lisha L, Takatsuki K: p53 gene mutation and loss of heterozygosity are associated with increased risk of disease progression in adult T-cell leukemia. Leukemia 9:598, 1995.